
Investors Face August Deadline in GeneDx Securities Class Action
Investors who purchased GeneDx Holdings Corp. common stock between April 16, 2025, and May 4, 2026, face an August 3, 2026, deadline to seek appointment as lead plaintiff in a class action lawsuit. The litigation claims the company misled shareholders regarding the viability of its Fabric Genomics acquisition.


























